An update on the evidence base for peginterferon β1a in the treatment of relapsing-remitting multiple sclerosis. Bhargava P, Newsome SD Ther Adv Neurol Disord. 2016 Nov; 9(6):483-490. PMID: 27800024. Abstract CommentRecommendBookmarkWatch
